Evolent Health (EVH) Net Cash Flow (2015 - 2026)

Evolent Health's Net Cash Flow history runs 12 years deep, the most recent figure standing at -$11.4 million for Q1 2026.

• On a quarterly basis, Net Cash Flow fell 111.44% year-over-year to -$11.4 million in Q1 2026; TTM through Mar 2026 was -$108.0 million, a 342.51% decrease from a year earlier, with the FY2025 full-year figure at $2.7 million, up 106.0% from the prior year.
• Net Cash Flow slipped to -$11.4 million in Q1 2026 per EVH's latest filing, from $37.9 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $99.3 million in Q1 2025 and bottomed at -$99.8 million in Q2 2025.
• The 5-year median for Net Cash Flow is -$1.0 million (2023), against an average of -$10.8 million.
• Biggest YoY gain for Net Cash Flow was 5063.93% in 2024; the steepest drop was 711.04% in 2024.
• Year by year, Net Cash Flow stood at $20.4 million in 2022, then sank by 105.02% to -$1.0 million in 2023, then soared by 5063.93% to $50.8 million in 2024, then fell by 25.33% to $37.9 million in 2025, then slumped by 129.97% to -$11.4 million in 2026.
• Per Business Quant, the three latest EVH Net Cash Flow figures stand at -$11.4 million (Q1 2026), $37.9 million (Q4 2025), and -$34.8 million (Q3 2025).